Abeona Therapeutics Appoints Mohamad Tabrizi As Chief Business Officer To Lead Strategy, Business Development, And Operational Efficiency

Abeona Therapeutics Inc., a Nasdaq-listed biopharmaceutical company, has announced the appointment of Mohamad Tabrizi as Senior Vice President and Chief Business Officer. In this role, he will be responsible for leading the company’s corporate strategy and business development activities, while also focusing on improving overall operating efficiency.

Vish Seshadri, Chief Executive Officer of Abeona, said that Mr. Tabrizi brings deep experience in strategic planning and business development, along with a strong industry network. He noted that the company looks forward to leveraging this expertise to strengthen operations and advance value-creating partnerships that support Abeona’s long-term growth.

Mr. Tabrizi joins Abeona from the venture capital sector, where he served as a General Partner and Managing Director at Pandect Bioventures and the Berkeley Catalyst Fund. In these roles, he led investment strategies and portfolio management and also took on hands-on operational leadership positions within portfolio companies. His experience includes serving as Chief Executive Officer of Azkarra Therapeutics and as Interim Chief Financial Officer of Circle Pharma. His commercial expertise is supported by a strong scientific background, including research fellowships and associate roles at the Howard Hughes Medical Institute and Stanford University Medical School.

Earlier in his career, Mr. Tabrizi built an extensive track record in corporate development and capital markets. From 2007 to 2017, he served as Executive Director of Corporate Business Development at Nektar Therapeutics, where he completed 20 strategic transactions and established collaborations with leading pharmaceutical and biotechnology companies, including AstraZeneca, Bristol-Myers Squibb, Pfizer, Merck, and Amgen. Prior to that, he worked as a healthcare investment banker at RBC Capital Markets and Needham & Company, where he led more than 40 transactions and helped raise over $5 billion through public and private financings.

Mr. Tabrizi holds a Master of Business Administration degree from Cornell University, a Master of Science in Biological Sciences from Stanford University, and a Bachelor of Science in Genetics from the University of California, Davis.